Mild, reversible ocular inflammation has been reported during clinical trials. Eybelis should be used with caution in patients with active ocular inflammation, including iritis/uveitis (see 'Adverse Reactions').
Macular edema including cystoid macular edema as well as iritis may occur. Patients should be instructed to immediately consult with medical professionals if they experience abnormalities such as worsening vision (see 'Adverse Reactions').
There is no clinical experience in patients with angle-closure glaucoma. It is advisable to use with caution in patients with angle-closure glaucoma.
Effects on ability to drive and use machine: Because temporary blurred vision or photophobia may develop after instilling this product, patients should be instructed not to drive or to operate machines until the symptom disappears.